Form 4: Volcon Co-CEO Kyoung John Kim Boosts Stake and Receives Performance-Based Stock Options

Volcon, Inc.'s Co-Chief Executive Officer, Kyoung John Kim, acquired 22,500 shares of common stock in a private placement and was granted new stock options totaling 1,674,385 shares.

Summary

• Kyoung John Kim, Co-Chief Executive Officer and Director of Volcon, Inc. (VLCN), reported changes in beneficial ownership.
• Acquired 22,500 shares of common stock at $10 per share on July 21, 2025, through a private placement with accredited and institutional investors.
• Received a grant of 180,375 stock options on July 17, 2025, with an exercise price of $10, expiring May 30, 2035. This grant was an amendment to an existing agreement, adjusted for a 1-for-8 reverse stock split on June 11, 2025, and increased the exercise price to $10.
• Received an additional grant of 1,494,010 stock options on July 17, 2025, with an exercise price of $10, expiring July 17, 2035. These options vest based on the daily volume weighted average price (VWAP) of the common stock, with 20% vesting upon VWAP reaching $10 and full vesting upon VWAP reaching $30.
• Both new stock option grants are subject to approval by the Issuer's stockholders of a new stock option plan.

Sentiment

Score: 7

Explanation: The insider purchase and significant performance-based option grants indicate management confidence and alignment with shareholder interests. However, the contingency of stockholder approval for options and the recent reverse stock split introduce some uncertainty and suggest past stock performance challenges.

Positives

• Co-CEO Kyoung John Kim purchased 22,500 shares of common stock in a private placement at $10 per share, indicating direct financial commitment and confidence in the company's future.
• The Co-CEO received significant performance-based stock option grants totaling 1,674,385 shares, aligning management's incentives directly with shareholder value creation, particularly through VWAP-based vesting targets.

Negatives

• The vesting of a substantial portion of the Co-CEO's stock options (1,494,010 shares) and the amendment to the smaller grant (180,375 shares) are contingent upon stockholder approval of a new stock option plan, introducing a potential hurdle.
• The exercise price for all options is $10, meaning the stock price must appreciate significantly above this level for the options to be in-the-money and provide value.

Risks

• The vesting of 1,674,385 stock options granted to the Co-CEO is contingent upon stockholder approval of a new stock option plan, which could impact executive compensation and retention if not approved.
• The company underwent a 1-for-8 reverse stock split on June 11, 2025, which can sometimes be indicative of past stock price underperformance or efforts to meet exchange listing requirements.

Future Outlook

The vesting of a significant portion of the Co-CEO's stock options is tied to the company's stock price reaching specific volume weighted average price (VWAP) thresholds ($10 and $30), indicating an expectation of future stock appreciation. However, these grants are contingent on stockholder approval of a new stock option plan.

Management Comments

• "The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025."
• "The Reporting Person and the Issuer amended an existing option grant agreement pursuant to which the Reporting Person was granted options to purchase 180,375 shares of common stock of the Issuer (as adjusted for the Issuer's June 11, 2025 one-for-eight reverse stock split) in connection with the Reporting Person's employment service to the Company. The amendment increased the exercise price of such options to $10 per share of common stock."
• "The stock options vest based upon the daily volume weighted average price ('VWAP') of the Issuer's common stock, vesting as to 20% of the of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan."
• "The stock options were issued by the Issuer in connection with the Reporting Person's employment service as Co-Chief Executive Officer of the Issuer on July 17, 2025. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan."

Industry Context

This filing reflects standard executive compensation practices involving equity grants and insider purchases, common across industries to align management interests with shareholders. The VWAP-based vesting is a performance-based incentive. The recent reverse stock split suggests the company may be addressing compliance with exchange listing requirements or aiming to improve stock perception, a common occurrence for smaller cap companies.

Comparison to Industry Standards

• The private placement purchase by an insider at a fixed price is a strong signal of confidence, often seen in companies seeking to stabilize or boost investor sentiment, similar to how executives at struggling tech startups might participate in funding rounds.
• Performance-based vesting for executive options, tied to stock price milestones (VWAP reaching $10, $30), is a common practice in growth-oriented companies, comparable to how Tesla or other high-growth companies structure executive incentives to drive significant shareholder returns.
• The 1-for-8 reverse stock split is a significant capital structure change, often employed by companies like AMC Entertainment or Bed Bath & Beyond when their stock price falls below exchange minimums, aiming to increase per-share price and marketability.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from option grants if exercised, but also potential benefit from management's incentivized performance and insider buying. The reverse stock split impacts share count and per-share price.
• Management/Employees: Co-CEO's compensation is significantly tied to stock performance, aligning interests.

Next Steps

• Stockholder approval of a new stock option plan is required for the vesting of the granted options.
• Monitoring the company's stock price to observe if the VWAP thresholds ($10, $30) for option vesting are met.

Key Dates

Keywords

Volcon Inc., VLCN, SEC Form 4, Beneficial Ownership, Stock Options, Private Placement, Executive Compensation, Kyoung John Kim, Co-Chief Executive Officer, Reverse Stock Split, Equity Grant, Insider Buying